The Swiss Prison Study (SWIPS): Protocol for a public health registry among prisoners by Gaisl, Thomas et al.








The Swiss Prison Study (SWIPS): Protocol for a public health registry
among prisoners
Gaisl, Thomas ; Musli, Naser ; Baumgartner, Patrick ; Meier, Marc ; Rampini, Silvana K ; Blozik, Eva ;
Battegay, Edouard ; Kohler, Malcolm ; Saxena, Shekhar
Abstract: Background: Health aspects, disease frequencies, and specific health interests of prisoners and
refugees are poorly understood. Importantly, access to the healthcare system is limited for this vulnerable
population. Objective: Currently, there has been no systematic investigation to understand the health
issues of inmates in Switzerland. Furthermore, little is known on how recent migration flows in Europe
may have impacted the health conditions of inmates in recent years. We therefore planned a large-
scale observational study to establish a public health registry in northern-central Switzerland. Methods:
Demographic and health-related data, such as age, sex, country of origin, duration of imprisonment,
medication (including the drug name, brand, dosage, and release), medical history (including the ICD
codes for all diagnoses and external results that are part of the medical history in the prison) will be
deposited in a central register over a span of five years (April 2015 to April 2020). The final cohort
is expected to comprise approximately 50,000 to 60,000 prisoners from the Police Prison Zurich (PPZ),
Switzerland. The primary objective is to establish a central database to assess disease prevalence (i.e., ICD
codes) among prisoners. The secondary objectives include the following: (1) to compare the 2015 to 2020
disease prevalence among inmates against a representative sample from the local resident population; (2)
to assess longitudinal changes in disease prevalence from 2015 to 2020 using cross-sectional medical records
from all inmates at the PPZ; and (3) to identify unrecognized health problems to prepare successful public
health strategies. Results: The current study was funded in August 2020 by the ”Walter and Gertrud
Siegenthaler” foundation and the ”Theodor and Ida Herzog-Egli” foundation and approved by the IRB
in August 2019. Data collection started in August 2019 and results are expected to be published in
2021. Findings will be disseminated through scientific articles as well as presentations and public events.
Conclusions: None Clinical Trial: ISRCTN registry (www.isrctn.com/ISRCTN11714665)
DOI: https://doi.org/10.2196/23973





Gaisl, Thomas; Musli, Naser; Baumgartner, Patrick; Meier, Marc; Rampini, Silvana K; Blozik, Eva; Bat-
tegay, Edouard; Kohler, Malcolm; Saxena, Shekhar (2020). The Swiss Prison Study (SWIPS): Protocol
for a public health registry among prisoners. JMIR research protocols, 9(12):e23973.
DOI: https://doi.org/10.2196/23973
JMIR Preprints Gaisl et al
The Swiss Prison Study (SWIPS): Protocol for a public
health registry among prisoners
 Thomas Gaisl, Naser Musli, Patrick Baumgartner, Marc Meier, Silvana K.
Rampini, Eva Blozik, Edouard Battegay, Malcolm Kohler, Shekhar Saxena
Submitted to: JMIR Research Protocols
on: August 30, 2020
Disclaimer: © The authors. All rights reserved. This is a privileged document currently under peer-review/community
review. Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for
review purposes only. While the final peer-reviewed paper may be licensed under a CC BY license on publication, at this
stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.
https://preprints.jmir.org/preprint/23973 [unpublished, peer-reviewed preprint]
JMIR Preprints Gaisl et al
Table of Contents
Original Manuscript ....................................................................................................................................................................... 5
Supplementary Files ..................................................................................................................................................................... 26
  ................................................................................................................................................................................................... 26
Figures ......................................................................................................................................................................................... 27
Figure 1 ...................................................................................................................................................................................... 28
https://preprints.jmir.org/preprint/23973 [unpublished, peer-reviewed preprint]
JMIR Preprints Gaisl et al




 MD; Naser Musli
1
 MD; Patrick Baumgartner
1
 BSc; Marc Meier
1





 MD; Edouard Battegay
1
 MD; Malcolm Kohler
1
 MD; Shekhar Saxena
2
1
University Hospital Zurich Zurich CH
2
Harvard T H Chan School of Public Health Boston US
3








Background: Health aspects, disease frequencies, and specific health interests of prisoners and refugees are poorly understood.
Importantly, access to the healthcare system is limited for this vulnerable population.
Objective: Currently, there has been no systematic investigation to understand the health issues of inmates in Switzerland.
Furthermore, little is known on how recent migration flows in Europe may have impacted the health conditions of inmates in
recent years. We therefore planned a large-scale observational study to establish a public health registry in northern-central
Switzerland.
Methods: Demographic and health-related data, such as age, sex, country of origin, duration of imprisonment, medication
(including the drug name, brand, dosage, and release), medical history (including the ICD codes for all diagnoses and external
results that are part of the medical history in the prison) will be deposited in a central register over a span of five years (April
2015 to April 2020). The final cohort is expected to comprise approximately 50,000 to 60,000 prisoners from the Police Prison
Zurich (PPZ), Switzerland. The primary objective is to establish a central database to assess disease prevalence (i.e., ICD codes)
among prisoners. The secondary objectives include the following: (1) to compare the 2015 to 2020 disease prevalence among
inmates against a representative sample from the local resident population; (2) to assess longitudinal changes in disease
prevalence from 2015 to 2020 using cross-sectional medical records from all inmates at the PPZ; and (3) to identify
unrecognized health problems to prepare successful public health strategies.
Results: The current study was funded in August 2020 by the "Walter and Gertrud Siegenthaler" foundation and the "Theodor
and Ida Herzog-Egli" foundation and approved by the IRB in August 2019. Data collection started in August 2019 and results are
expected to be published in 2021. Findings will be disseminated through scientific articles as well as presentations and public
events.
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Abstract
Background. Health aspects, disease frequencies, and specific health interests of prisoners and refugees are
poorly understood.  Importantly,  access  to  the healthcare system is limited for this  vulnerable  population.
Currently,  there  has  been  no  systematic  investigation  to  understand  the  health  issues  of  inmates  in
Switzerland. Furthermore, little is known on how recent migration flows in Europe may have impacted the
health conditions of inmates. 
Objectives. The Swiss Prison Study (SWIPS) is a large-scale observational study with the aim of establishing
a  public  health  registry  in  northern-central  Switzerland.  The  primary  objective  is  to  establish  a  central
database  to  assess  disease  prevalence  (i.e.,  ICD-10 codes  [German Modification])  among prisoners.  The
secondary  objectives  include  the following:  (1)  to  compare the  2015 to 2020 disease  prevalence among
inmates against a representative sample from the local resident population; (2) to assess longitudinal changes
in disease prevalence from 2015 to 2020 using cross-sectional medical records from all inmates at the PPZ;
and (3) to identify unrecognized health problems to prepare successful public health strategies.
Methods. Demographic and health-related data, such as age, sex, country of origin, duration of imprisonment,
medication (including the drug name, brand,  dosage,  and release),  medical history (including the ICD-10
codes [German Modification] for all diagnoses and external results that are part of the medical history in the
prison) will be deposited in a central register over a span of five years (January 2015 to August 2020). The
final cohort is expected to comprise approximately 50,000 to 60,000 prisoners from the Police Prison Zurich
(PPZ), Switzerland. 
Results. The current study was funded in August 2020 by the "Walter and Gertrud Siegenthaler" foundation
and the "Theodor and Ida Herzog-Egli" foundation and approved by the IRB in August 2019. The study was
registered with the ISRCTN registry (www.isrctn.com/ISRCTN11714665). Data collection started in August
2019 and results  are  expected to  be published in  2021.  Findings will  be disseminated through scientific
articles as well as presentations and public events. 
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Trial registration
ISRCTN registry (www.isrctn.com/ISRCTN11714665)
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Introduction
In  institutions  such  as  prisons  and  correctional  facilities,  health  risks  are  disproportionately
widespread.  It  is estimated that approximately 6 million  people are incarcerated every year in the
World Health Organization (WHO) European Region.[1] The health profile of  people in prison is
complex and risk factors for poor health often overlap with risk factors for incarceration.  [2] Co-
occurring physical and mental health conditions are often found in close association to entrenched and
intergenerational  social  disadvantage.[3]  Data  indicate  that,  in  general,  prisoners  are  sicker  when
compared with counterparts of the same age, race, and sex in free society.[4] Additionally, prisons and
detention centers are known to reduce resources for inmates substantially, and disease frequencies and
the health of individual prisoners are poorly understood owing to a lack of original data.[1] Finally,
many inmates lack opportunities to articulate themselves (e.g. language barriers in Europe), and access
to  the  healthcare  system is  extremely  limited.  Prison  physicians  often  speak  of  a  “blind  spot  in
society.”[5] In contrast to the judicial branch which is obliged to publish numbers on the origin, age,
sex, and penalties of convicts, systematic investigations on the health issues of inmates are extremely
rare. 
Current situation. Only a few prevalence studies conducted in the United States and Europe indicate
that the disease profile of prison inmates is significantly different from that of the general population.
In line with what is generally known about the health of people in prison, data from the Health in
Prisons European Database (HIPED) paint a picture of an extremely vulnerable population that suffers
from  poor  health  and  engages  in  risky  health  behaviors,  leading  to  noncommunicable  and
communicable diseases and mental health conditions.[1, 6]  
In this setting, drugs and non-medical use of conventional medications seem to play a crucial role in
the health of people in prison.[6] In 2014, a report from the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) suggested, that besides health-related problems, illicit drug use is
highly  prevalent  among people  in  prison.[7]  More  recently,  the  EMCDDA has  warned about  the
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rapidly developing phenomenon of the use of new psychoactive substances (NPS) among prisoners.[8]
Monitoring data indicates, that prisons are the epicenter of a this phenomenon and there is growing
concern  that  NPS  may  be  responsible  for  a  large  share  of  drug-related  problems  in  prison.[8]
Approximately  4% to  56% of  all  inmates  use  psychoactive  substances,  but  the  exact  percentage
requires further investigation.[4, 9] For comparison, there is ample evidence that the “opioid crisis” in
the  United  States  affects  inmates  in  particular.[10]  Currently,  only  limited  data  from  European
institutions are available.[8] Studies conducted in the United States, estimate that the “off-label” usage
of drugs in prisons is about 36.2%.[11] Once again, no comparable data from Switzerland are available
and  there  seems  to  be  a  lack  of  systematically  collected  and  comparable  data  on  the  health  of
incarcerated people.
In  2017,  approximately  71%  of  prison  inmates  in  Switzerland  were  foreigners  and  most  were
imprisoned in the Canton of  Zurich.[12]  One  way of  systematically  recording specific  aspects  of
disease burden in this population is to analyze medical files and histories. From past studies performed
in the early 2000s, it has been established that analysis of medical records in prisons is an extremely
reliable  source.  In  fact,  in  some  areas  of  disease  burden  (e.g.  infections  disease,  assessment  of
cardiovascular  risk)  this  can be considered superior  to  information gained from questionnaires  or
personal interviews.[9, 13] Most importantly, a systematic collection and analysis of medical records
has not yet been conducted for inmates in Switzerland. 
Police Prison Zurich (PPZ). Prison facilities are required to ensure adequate health care in both the
somatic and psychiatric fields. When considering the PPZ, the University Hospital Zurich has taken
over  the responsibility  for  providing somatic  and psychiatric  care.  The  PPZ is  the largest  inmate
correctional facility in Switzerland in Switzerland and approximately 10,000 to 12,000 prisoners are
admitted per year. Data from the Federal Statistical Office in Switzerland indicate that inmates held for
pre-trial detention are predominantly young, male, and approximately 75% are non-Swiss nationals
(Figure 1). [12] Anecdotal evidence suggests that a large proportion of inmates (e.g., refugees, among
others) have reported previously using drugs that were prescribed for off-label purposes. One example
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is  the  prevalent  purchase  of  the substance  pregabalin via  online pharmacies.[14]  Other  examples
include the underestimated usage of recreational drugs (e.g., clonazepam) and other NPS.[15] Most of
these drugs have potentially substantive health consequences, mainly attributed to their high potential
for addiction and adverse effects. Furthermore, little information has been established on how recent
refugee patterns may have impacted the health conditions of inmates in recent years.
Hypothesis.  In summary, the prison population is very vulnerable; yet,  hardly any reliable data is
available on the health of inmates.[1, 3] The current geopolitical situation appears to exacerbate the
problem as patients with a disproportionately poor health status have contact with the Swiss health
care system. Data from the PPZ offers a unique opportunity globally for a representative analysis of
the disease profile of inmates. The aim of this study is to collect health-related data in order to give
insight into an unexplored area and underserved patient population. 
We hypothesize (see Table 1) that the disease profile of inmates substantially differs from that of the
general  population.  Specifically,  certain  chronic  and  psychiatric  diseases  are  disproportionately
prevalent among inmates and refugees. Second, a large number of drugs (e.g., NPS) may be used “off-
label” and the origin of the inmates and the refugee route, respectively, may have an impact on the
disease profile  of  the affected.  Finally,  recent  geopolitical  changes have significantly affected the
overall disease profile of inmates.
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Methods 
Study  design.  This  is  an  observational  study  with  a  population-based  cross-sectional  baseline
measurement and no prospective follow-up. 
Study objectives. The primary objective is to establish a central database to assess the prevalence of
diseases (i.e., ICD-10 codes [German Modification]) among prisoners. The secondary objectives are
(1)  to  compare  the  2015 versus  2020 disease  prevalence  among inmates  against  a  representative
sample from the local resident population; (2) to assess longitudinal changes in disease prevalence
from 2015 to 2020 using cross-sectional medical records from all inmates at the PPZ. Achieving these
objectives promises to lead to new public health insights and the resulting database should allow for
identification  of  unrecognized  health  problems  to  formulate  models  for  successful  public  health
strategies.
Study questions. The main questions under investigation include the following:
1. What  is  the  health  status  of  the  inmate  population  and  which  conditions  are  over-  and
underrepresented in the prison setting? In particular, how do psychiatric diseases affect inmates
and  what  is  the  estimated  prevalence  of  substance  abuse  in  the  prison  population?  Which
infectious  diseases  (e.g.,  tuberculosis,  pneumonia,  scabies,  etc.)  are  highly  prevalent  among
inmates and what are the comorbidities of this population.
2. What are the dynamics in the health profile of inmates (and thus refugees) during the European
migrant crisis from 2015 onwards and how does the epidemiology of the prison population affect
the balance between acute and chronic conditions?
3. Are  there  under-recognized  health  problems  among  vulnerable  populations  (e.g.,  children,
pregnant mothers, patients with suicidal ideation),  or  overrepresented populations (e.g.,  body-
packer, patients with traumatic injuries).
Study site. The health registry is based at the PPZ (Kasernenstrasse 29, 8021 Zurich, Switzerland). In
this  prison,  all  inmates  of  the  Canton  of  Zurich  are  detained  for  up  to  a  maximum  of  7  days.
Afterwards,  prisoners are transferred to either 1) pre-trial  detention,  2)  serving a particular  prison
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sentence in a long-term facility, 3) anticipatory execution of sentence, or, 4) coercive measures are
applied based on aliens law. The PPZ is the only central police prison in the Canton of Zurich serving
a population of 1,520,968 (as  of December 31,  2018),  which is  the most  populous canton in  the
country. This prison has approximately 10,000 to 12,000 inmates yearly, of which about a third require
medical  attention (based on historical data from the PPZ / not published).  The entire spectrum of
medical attention needed to meet inmates’ medical needs is covered within the PPZ, such as general
internal medicine (e.g., asthma), traumatic injuries, psychiatric emergencies, and infectious diseases
(e.g., HIV). 
Participants.  This study will  enroll prisoners within the  PPZ from April 1, 2015 until  August 31,
2020. The final sample will be exhaustive. All inmates within this timeframe will be included in this
study and there will be no random selection. Only in documented cases where a prisoner allegedly
refuses to participate in health-related activities, they will be excluded from the study, and their data
will not be analyzed. Otherwise, there are no exclusion criteria. Extrapolating from current numbers
(approx. 850 prisoners per month x 64 months), it is expected that the final database will contain data
from approximately 50,000 to 60,000 prisoners.
Cooperation. The study will be conducted in cooperation with the Cantonal Police Zurich (contact
person: Ms. Iris Suter), the University Hospital Zurich which is the designated medical authority for
the  PPZ, and the Helsana AG (contact person: Dr. Eva Blozik). The Helsana AG is a major Swiss
health insurance company with 2.1 million customers insured and will  provide data on a matched
Swiss  cohort.  Data  will  be  extracted  from  the  Helsana  Drug  Report[16],  which  is  created  in
cooperation with the University Hospital Basel and the Institute for Pharmaceutical Medicine at the
University of Basel. Another study site includes the University Hospital Zurich, Switzerland which
contractually provides all  outpatient  and inpatient  medical  care for the  PPZ, including psychiatric
consultations. No other parties are involved in the medical care of the PPZ prisoners. 
Data  collection  and  management.  Data  entry  into  the  health  registry  will  be  performed
synchronously  or  asynchronously  by  a  study  team  of  physicians  (T.G.,  N.M,  P.B.,  M.M.)  after
carefully reviewing the source documents. A unique electronic case report form based on the variables
in Table 2 and 3 was developed at the inception of this study. All source documents must be placed
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within the medical history of the prisoner. Tables 2 and 3 summarize both the parameters and domains
used in  the study,  which includes all  variables,  and other  data extracted from the health registry.
Unclear documentation will be discussed among the study team and incomplete data will be made
apparent in the registry. After data entry, data will be checked for completeness and plausibility by the
data manager. The database will be encrypted and only study personnel will have access to the source
documents which will not leave the prison. Encrypted backups of the database will be periodically
conducted using external hard drives. 
Quality control.  For this health registry,  the following four quality control  measurements will  be
implemented, and the results will be provided in the final manuscript:
1. Inter-observer variability: the source documentation of 150 random patients will be processed by
two physicians (i.e. 450 degrees of freedom for every variable will be assessed) and disparities
observed with regard to all domains (Tables 2 and 3) will be summarized.
2. Matching  with  a  local  database  from  the  jurisdiction:  data  from the  health  registry  will  be
compared with data from the jurisdiction, and discrepancies (e.g., country of origin, etc.) will be
further investigated by the study team.
3. Internal validity: the consumption of medications will be summarized for each month from 2015
to 2020, and this data will be compared with the prescription data collected from the PPZ’s local
pharmacy which collects monthly data for all dispensed medication. This step ensures that the
actually dispensed medication is equal to the prescribed medication.
4. Verification of the source documents: Foreign health-related documents must be checked and if
necessary, translated to German by a recognized body (e.g., translation services). In case of an
already established course of treatment pharmaceutical drugs with the dispensing category “A+”,
according to the Federal Act on Medicinal Products and Medical Devices (Therapeutic Products
Act, TPA) article 24 (e.g., opioids, benzodiazepines methylphenidate, etc.), require an external
verification of the original prescription and a statement from the physician. Written verifications
by  the  federal  authorities  and/or  non-governmental  organizations  involved  in  the  opioid
replacement  therapy program will  also be accepted.  Other  verifications  by non-governmental
organizations (e.g., refugee organizations) will not be accepted. 
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Data protection. In this registry, anonymized health data will be analyzed and stored. Other sensitive
data, particularly religious, political, social security, or administrative data, will not be included as part
of this study. The anonymized datasets generated and/or analyzed during the current study will  be
available upon request from T.G. Data are handled according to the Schengen Data Protection Act. 
Statistical considerations. Statistical analyses will be conducted by the study team in consultation
with senior statisticians. For baseline analyses, means or medians will be reported according to the
distribution of  the continuous variable.  Proportions  will  be reported for  categorical  variables.  For
hypothesis testing, a t-test for normally distributed continuous variables and non-parametric tests for
non-normally distributed continuous variables will be conducted; χ2 testing will be used for categorical
variables.  Linear  and/or  logistic  regression  models  with  or  without  adjustment  for  potential
confounders (i.e. age, sex, nationality) will be used when appropriate. Regression analysis estimates
will be reported using 95% confidence intervals, and a two-sided p-value of <0.05 will be considered
statistically  significant  for all  reported tests.  For  the longitudinal  data,  a  generalized linear mixed
model with random effects (accounting for the nationality of the prisoner during the refugee crisis)
will  be  used  when  appropriate.  Statistical  analyses  will  be  performed  using  STATA Version  16
(StataCorp LP, College Station, TX).
Outcomes. The primary outcome measure will be disease prevalence using cross-sectional data from
prisoner’s medical records (i.e., using the ICD-10 codes [German Modification]) from 2015 to 2020.
Secondary outcome measures include the following:
1. A comparison of disease prevalence (ICD-10 codes [German Modification]) of the inmates at the
PPZ to a representative sample from the local resident population using cross-sectional medical
records from all inmates at the PPZ from 2015 to 2020. 
2. Longitudinal changes in disease prevalence (ICD-10 codes [German Modification]) from 2015 to
2020 using cross-sectional medical records from all inmates at the PPZ.
Ethical aspects.  The study was approved by the Ethical Committee of the Canton of Zurich. The
committee will be informed about major changes to the protocol in agreement with local requirements.
The study will  be conducted in accordance with the protocol and the principles enunciated in the
current version of the Declaration of Helsinki, the guidelines of Good Clinical Practice issued by the
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International  Conference on Harmonization,  and the requirements  from the Swiss Law and Swiss
regulatory authorities. The study protocol is reported according to the reporting adheres to SPIRIT
guidelines, and results will be reported according to the STROBE statement from the University of
Basel, Switzerland. 
Results
The current study was funded in August 2020 by the "Walter and Gertrud Siegenthaler" foundation
and the "Theodor and Ida Herzog-Egli" foundation and approved by the IRB in August 2019. Data
collection started in August 2019 and results are expected to be published in 2021. Findings will be
disseminated through scientific articles as well as presentations and public events.
Discussion
This  health  registry is  designed to provide new public  health  insights  into a  group of  vulnerable
patients. The implementation of the study protocol promises to allow for the identification of specific
health problems to help prepare successful public health strategies to meet these challenges. To gain a
representative  sample  from  the  Canton  of  Zurich  inmate  population,  this  study  required  a  high
enrollment. Inmates at the PPZ usually spend a minimum of one day to a maximum of seven days in
the facility, are internationally mobile, often unable to speak German, and have no contact details
provided. Gaining informed consent from each prisoner is a disproportionately large expenditure. In
this current observational study, we assume that the expected increase in knowledge will benefit future
inmates and thus, outweigh the disadvantages associated with privacy concerns. Moreover, given these
operational  challenges,  any  large-scale  study  on  the  prisoner  population  will  likely  need  to  be
conducted without receiving individualized informed written consent. Thus, in accordance with the
Swiss Human Research Act article 34, the need to obtain informed consent is waived for this study and
data collected from all  prisoners will  be gathered.  Only in case of documented alleged refusal  to
participate in health-related activities, then data from the prisoner will not be included in this study.
Currently, no similar observational studies on Swiss inmates are available. Data from the United States
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and European registries indicate, that  prisoners are sicker when compared with counterparts in free
society.[2-4] However, these data are limited to a certain location and time and they do not investigate
changes over time within a certain cohort. Preliminary studies suggest, that illicit drugs and especially
NPS are a growing problem in European prisons but only limited data from European prisons are
available.[7,8] The current study will be able to draw conclusions on these issues based on a 5-year
representative sample of approximately 50,000 to 60,000 prisoners from the PPZ. Thus, this study will
add valid evidence to  the current  health status of  prisoners and findings can be used to promote
healthy behaviors (e.g. future intervention studies) and/or policy change for this population. 
The findings of the study will be disseminated through peer-reviewed journals, as well as national and
international  conference  presentations.  Collaborations  with  other  researchers  in  the  field  will  be
promoted. The data that support the findings of this study are available from the corresponding author,
upon reasonable request. Furthermore, data will be presented to Swiss policymakers and healthcare
workers to improve the public health of prisoners in Switzerland. In conclusion, the present study will
construct a valuable database of information regarding the health of inmates and refugees and will act
as groundwork for future interventions in this vulnerable population.
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List of abbreviations
GCP Good Clinical Practice
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
HIPED Health in Prisons European Database
HRA Swiss Human Research Act
ICD International Classification of Diseases
NPS New Psychoactive Substances 
PPZ Police Prison Zurich
SDPA Schengen Data Protection Act
TPA Therapeutic Products Act
WHO World Health Organization
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Tables
Table 1. Hypothesis for the study protocol.
1.
The  disease  profile  of  inmates  substantially  differs  from  that  of  the
general population. Specifically, certain chronic and psychiatric diseases
are disproportionately prevalent among inmates and refugees.
2.
Recent geopolitical changes (e.g. refugee patterns) significantly affected
the overall disease profile of inmates in the prisons.
3.
A large number of drugs (e.g. new psychoactive substances, NPS) may
be used “off label” and their prevalence may be underestimated.
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Table 2. Summary table of the general domains and parameters, which will be part of the registry.
Domain Parameter Comment
General characteristics
Age, years Years at Baseline
Sex, (male, female) Male / Female
Date of imprisonment Date
Length of imprisonment Days
Country of origin
Sovereign state according to the
United Nations
Diagnosis
Principal diagnosis ICD-10 code
German Modification of
the ICD





















of drugs with dispensing
category “A+”*
CT, computed tomography, ICD, International Classification of Diseases
* Category A+ according to the Federal Act on Medicinal Products and Medical Devices (Therapeutic
Products Act, TPA) article 24 (e.g., opioids, benzodiazepines methylphenidate, etc.)
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Table 3. Summary of the systematic characteristics which will be assessed in the registry.
Particular characteristics at admission
Reason  for  consulting  a  physician  during  the
imprisonment?
Text





Need for a “Hafterstehungsfähigkeit”* ? Yes / No
History of illicit drug abuse? Yes / No
Participant  in  the  opioid  replacement  therapy
program?
Yes / No
History of benzodiazepine dependence? Yes / No




Result of the alcohol breath test at admission? Milligram per Litre optional
Evidence of body packing (according to CT scan
results)?
Yes / No
Particular characteristics during the imprisonment
Need  to  consult  a  psychiatrist  during
imprisonment
Yes / No
Admission to a hospital during imprisonment Yes / No
Special reports
Blood pressure chart Source document optional
Blood sugar chart Source document optional
Medical history
External documents Source document optional
Laboratory results (incl. pregnancy test) Source document optional
 * “Hafterstehungsfähigkeit“ = initial 24/7 medical assessment by a physician which decides, whether
the convict can be admitted to the prison in the first place
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Figure titles
Figure  1.  Insprisonment  statistics  for  pre-trial  detention  in  Switzerland  2020  from  the  Federal
Statistical Office. [12]
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